Src homology 2 domain containing transforming protein D (SHD)

Src homology 2 domain containing transforming protein D (SHD) is an intracellular adapter protein characterized by the presence of an SH2 domain. The SH2 domain enables this protein to bind phosphorylated tyrosine residues on other proteins, placing it centrally in signal transduction networks, particularly those involving receptor tyrosine kinases. SHD is predicted to interact in cellular signaling cascades and is part of a larger family of SH2 domain-containing adaptor proteins that help regulate cell proliferation, differentiation, and survival. While closely related SH2 domain adaptors are linked to diseases like cancer and immune dysfunction, SHD itself does not have extensively documented disease associations or pharmaceutical interactions as of the most current data[3][4][5][8][10].

Other names

SHDSH2 domain-containing adapter protein Dsrc homology 2 domain-containing transforming protein D

Drugs targeting SH2 domain-containing proteins typically act by modulating protein-protein interactions, inhibiting or enhancing downstream signal transduction (e.g., kinase, phosphatase inhibition), but none specific for SHD are reported.